NCT03025256 2026-04-02
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease
M.D. Anderson Cancer Center
Phase 1 Recruiting
M.D. Anderson Cancer Center
Stanford University
National Cancer Institute (NCI)
British Columbia Cancer Agency
National Cancer Centre, Singapore